Compare · women's metabolic health
Every provider we review, put side-by-side on the Luna Fit Score — our women's-health rubric weighing PCOS and hormonal suitability, clinical oversight and labs, price transparency, nationwide access, ongoing support and fair cancellation. Pick a matchup, or find alternatives to a provider you're weighing.
#1 for women
Luna Fit
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Grade A · leads the ranking at 93/100. See how it stacks up against any provider below.
Build your shortlist
Filter on what actually differs between GLP-1 programs for women — then tick any two to see the full head-to-head verdict.
Narrow the ranking
67 of 67 providers
Tick two providers to compare them directlyThe most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.
Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
A LegitScript-verified compounded program that charges one flat price at every dose — so titrating up to a working dose never quietly raises the bill.
Among the lowest verified prices we log — compounded semaglutide and tirzepatide on a single membership, shipped nationwide. A budget-first on-ramp for women who want tirzepatide access without paying a premium.
An insurance-first GLP-1 marketplace that shops a reader's coverage for her — down to $99/mo with qualifying insurance, or $50/mo for eligible Medicare Part D members through its CMS Bridge program — with one of the widest medication menus in this ranking, including an oral pill option.
A weight-focused program that also offers an oral/sublingual route — a genuine relief for the needle-averse and for anyone easing in gradually.
One of the few programs with a women's weight-loss line of its own, and the widest set of routes we track — injectable or sublingual, semaglutide or tirzepatide, each with its price on the page.
One of the deepest catalogs we log for a woman managing metabolism and hormones together — semaglutide and tirzepatide in oral, microdosed, and injectable forms, plus bioidentical HRT and a long peptide menu, from a LegitScript-certified, HIPAA-compliant compounder.
A GLP-1 program built explicitly for women — its product pages say so, and it sells HRT and menopause care beside the weight-loss line, which is a genuine draw if you are managing metabolism and hormones together. The $179 entry is real, but it is a yearly-subscription rate; no month-to-month price is published.
A high-transparency program with unusually clear clinician and supply-chain disclosure — you can see who is prescribing and where the medication comes from, which is rarer than it should be.
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
A rare combination for the price-conscious woman: rock-bottom compounded pricing on both molecules, an FDA-approved brand path, and LegitScript accreditation — a lot of clinical reassurance for very little money.
Names its six dispensing pharmacies and two NPI-verified physicians — disclosure few rows here offer — and then sells the whole thing on a single 12-week prepay whose advertised “$199/mo average” is that prepay divided by three, with no monthly rung to pick instead.
One of the few accredited programs pairing FDA-approved brand access with compounded on both molecules, nationwide — reassuring when you want a real clinical path for hormonal metabolic care.
A flat $179 a month at every dose, with the ongoing rate stated in writing rather than buried under an intro price — and you can cancel from your own dashboard, which is more than most of this ranking will commit to.
One of the very few programs here that will tell you who compounds your medication and who signs the prescription — four pharmacies named with phone numbers, two physicians named with NPIs that resolve — wrapped around a full menu that runs from compounded semaglutide to brand Zepbound.
An accredited, brand-capable program with mid-market pricing on both molecules — a balanced pick when you want FDA-approved options on the table alongside compounded.
Publishes more of its pricing than anything else in this ranking — all 70 rungs, in the open, each labeled with what it actually bills — and then prints the same wrong “from $129/mo” on all fourteen product cards, four of which it would overcharge.
One of the most complete feature sets we review for women: both molecules, an oral option, FDA-approved brand access, and LegitScript accreditation, all nationwide.
An accredited, all-50-states program that offers an oral option alongside injections — real flexibility for a woman easing into GLP-1 care.
Affordable, accredited, and nationwide — an easy on-ramp for a woman who wants tirzepatide at a fair price without sacrificing an oversight signal.
The one desk here that also sells the menopause side — estradiol as a patch, a gel or a pill plus progesterone — under the same intake as its GLP-1s, and the only line on the site whose price has no term table behind it.
One of the few programs we track that offers an oral or sublingual route alongside injections — semaglutide drops from about $179 (or $297 injectable), tirzepatide from about $224 — all-inclusive with no separate membership. The trade-off is a newer, less-verified operator whose prices we couldn't confirm live.
A straightforward accredited telehealth option with fair pricing on both molecules and nationwide reach — a solid middle-of-the-road choice.
A heavyweight platform with brand-name (Wegovy/Zepbound) access and insurance navigation — powerful if you want an FDA-approved product, but compounded pricing is opaque.
A wellness-app lineage brings a behavior-change sensibility to GLP-1 care — with an oral option and accreditation, though pricing sits mid-market.
A straightforward accredited telehealth program with both molecules nationwide — dependable middle-of-the-road care with a real oversight signal.
An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.
An accredited, nationwide program with predictable mid-market pricing on both molecules — a dependable if unremarkable choice.
A longevity-leaning brand whose hormone and healthy-aging catalog speaks directly to the perimenopause transition — plus some of the lower semaglutide pricing.
An established telehealth pharmacy with a broad metabolic and hormone catalog — handy if you want GLP-1 care inside a wider hormonal-wellness program.
Identical pricing on both molecules plus an oral option from an accredited platform — appealing if you want to switch between semaglutide and tirzepatide without a price penalty.
Low pricing on both molecules nationwide — attractive on cost, though the lack of LegitScript accreditation makes the oversight signal thinner.
Unusually specific about who fills the prescription: two PCAB-accredited compounding pharmacies named outright, a LegitScript ID you can look up, and a flat price at every dose with no membership fee bolted on.
An accredited, women-friendly brand offering an oral route nationwide — the trade-off is premium pricing on both molecules.
A flat-fee compounded pioneer — a simple, well-known model, but priced at the higher end now with no hormone-specific angle.
The Hers side is one of the few mass-market brands built around a women's identity — app-first, nationwide, though its hormonal depth is thin.
The only program in this ranking built for midlife first: your prescriber is a Menopause Society–certified physician, and weight care sits alongside a full hormone-therapy line rather than being sold in isolation.
The Bodybuilding.com brand's new compounded-telehealth arm publishes both ladders openly — semaglutide really does fall from $179/mo to $139/mo if you prepay a year, while its tirzepatide bundles cost MORE per month than its $209 month-to-month rate — wrapped around a deep sermorelin, NAD+, and peptide menu; real value on one molecule if you go in clear-eyed that it's compounded, brand-new, and final-sale.
A genuinely support-forward weight-care program with a strong care team — but limited state coverage and no accreditation weigh it down here.
The cheapest month-to-month price in the ranking by a wide margin, from a program that names all four of its compounding pharmacies — with the catch that it is a starting-dose promotional rate against a $299 list price, so it is the figure most likely to move.
One of the few programs here that puts both molecules in an oral form as well as an injection, alongside a real brand-name Ozempic lane — and it names the physicians behind the prescription, which few rows here do.
A flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it.
Three routes on one plan — semaglutide or tirzepatide by injection, or tirzepatide as sublingual drops if needles are the thing stopping you — with the dispensing pharmacy and the prescribing physician both named, and the physician's NPI actually resolving.
The only desk here that titrates against lean mass rather than scale weight — a weekly body scan is included — and the only one that will not tell you a price before you finish its assessment.
A physician-prescribed telehealth brand (Miami, founded 2021) that puts GLP-1 care on the same account as TRT, ED, NAD+, sermorelin and hair loss — genuinely broad, but built for a general and largely male-first audience rather than PCOS or hormonal care specific to women.
A compounded program sold as one-off packages rather than a subscription, in Spanish as well as English, charging $200/mo for semaglutide and $250 for tirzepatide at one flat rate per dose — but its own pages give nine different starting figures, none carrying a term and none of them the price it actually charges, plus two different answers on how many states it serves.
The rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you.
The clearest pricing structure in the ranking — compounded plans are all-in and month-to-month, brand plans say plainly that the drug is billed separately — paired with a dietitian and an insurance team, for the quarter of the country it actually covers.
A straightforward nationwide compounded program with NAD+ alongside the GLP-1 line — but it publishes one headline price and very little else.
A women-first brand with the clearest contraception guidance we found anywhere in this ranking — and an FDA warning letter for how it labeled its compounded products, which is the reason it does not rank higher.
A one-physician practice whose founder is menopause-certified and has written a 40-page perimenopause guide — genuine midlife expertise, wrapped around the most misleading price presentation in the ranking.
One of the few programs here that will prescribe brand-name Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited 24/7 access to its clinical team — though you will not find a GLP-1 price anywhere on its site.
Holds one price at every dose and names all four of its partner pharmacies with addresses — a rare pair of disclosures, wrapped in discount theater that does not survive a second look.
A wellness-lifestyle brand, not positioned around either gender, selling both molecules plus a named Microdose GLP-1+B12/NAD+ stack in two variants at one all-in price — with no named clinician or pharmacy behind any of it.
One of the few programs that documents its all-50-state footprint rather than asserting it, with an oral tirzepatide route and a starter-dose plan priced the same as the full dose.
A genuinely broad low-dose menu — eight microdose formulations, four of them oral, on top of both injectable molecules and a priced brand path — wrapped around a price you cannot pin down: the $59 and $99 headlines are conditional, and the rate you would actually be charged month to month appears nowhere before the medical intake.
A deliberately narrow program — two GLP-1s and nothing else, no hair, no testosterone, no upsells — priced the same at every dose, but it publishes neither its coverage map nor its cancellation terms.
Publishes its entire plan matrix in its own subscription terms — every tier, every dose band, every billing cadence — and then locks your price when the dose goes up, which is rarer than it sounds.
The best-documented exit terms we found — it publishes a worked example of how a canceled prepay is recalculated — attached to a site that still has last season's prices live on the same pages as this season's.
The broadest catalog in this ranking — compounded and brand-name semaglutide and tirzepatide, a named microdose tirzepatide product, NAD+, sermorelin and hair loss — with almost none of it priced before you start an intake.
Names the physician who reviews every intake and locks your price for life across every dose — then undercuts both promises with a banner price that matches nothing on sale and a refund policy that contradicts the storefront.
One price at any dose, three months of medication shipped up front — and a set of exit terms and unresolved compliance problems that make it the hardest program in this ranking to leave.
A beauty-adjacent brand name over gender-neutral copy, with the least verifiable pricing and the thinnest trust signals of any row in this ranking — no LegitScript badge, no named clinician or pharmacy, and no published state list.
Most-compared
Full index
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. The score is our editorial judgment per the methodology. Not medical advice; see our disclosure.